Multiple sclerose ontstaat door aftakeling van de myelineschede van zenuwen ten gevolge van ontstekingen die vaak een auto-immune oorsprong hebben. Genetica, leefstijl en omgeving beïnvloeden de ziekte, maar de impact van leefstijladviezen in de behandeling zijn nog te weinig onderzocht. Voeding gericht op ontstekingen kan misschien helpen en ook is er onderzoek gedaan rond biotine, groene thee, co-enzym Q10 en omega-3.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
http://msvn.ziektes.info/contents/multiple-sclerose/node/1257
Smoking en Epstein Barr virus
Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015 Mar;14(3):263-73. doi: 10.1016/S1474-4422(14)70267-4. Epub 2015 Feb 4. Review. PubMed PMID: 25662901.
PUFA
Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2012 Dec 12;12:CD004192. doi: 10.1002/14651858.CD004192.pub3. Review. PubMed PMID: 23235605.
Zout
Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN, Hafler DA. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013 Apr 25;496(7446):518-22
Ketogeen dieet
Storoni M, Plant GT. The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Mult Scler Int. 2015; 2015. doi: 10.1155/2015/681289 PMID: 26839705
Darm microbioom
Wekerle H. Nature plus nurture: the triggering of multiple sclerosis. Swiss medical weekly. 2015; 145: w14189. doi: 10.4414/smw.2015.14189 PMID: 26430854.
McLeod, J. G., Hammond, S. R., & Kurtzke, J. F. (2011). Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: A reassessment. I. Risk of MS by age at immigration. Journal of Neurology, 258, 1140–1149
Ascherio, A., Munger, K. L., White, R., Köchert, K., Simon, K. C., Polman, C. H.,Pohl, C. (2014). Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurology, 71, 306–314.
Mito
H. Lassmann, J. van Horssen, D. Mahad. Progressive multiple sclerosis: Pathology and mechanisms of tissue injury. Nature Rev. Neurol. 2012, 11:647-56
Kingwell E, Zhu F, Marrie RA, et al. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010). Journal of Neurology. 2015;262(10):2352-2363. doi:10.1007/s00415-015-7842-0.
Mähler A, Steiniger J, Bock M et al. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial. Am J Clin Nutr. 2015 Mar;101(3):487-95
Tremlett H et al, the US Network of Pediatric MS Centers. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol 2016; doi: 10.1111/ene.13026 (ahead of print)
Tremlett H et al. Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci. 2016 Apr 15;363:153-7.
Miyake S et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One. 2015 Sep 14;10(9):e0137429.
M.E. Witte, P.G. Nijland, J.A. Drexhage, W. Gerritsen, D. Geerts, B. van het Hof, A. Reijerkerk, H.E. de Vries, P. van der Valk, J. van Horssen. Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol. 2013, 2:231-243
Reichelt, K. L., & Jensen, D. (2004). IgA antibodies against gliadin and gluten in multiple sclerosis. Acta Neurologica Scandinavica, 110, 239–241.
K. Clarke, K. Tchabanenko, R. Pawlosky et al., “Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects,” Regulatory Toxicology and Pharmacology, vol. 63, no. 3, pp. 401–408, 2012
Pantzaris MC, Loukaides GN et al. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open. 2013 Apr 17;3(4)
